Delivery Order SPE2DB24D2205-SPE2DB25FEGNB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,334.12 on August 13, 2025, for Flarex 0.1% eye drops (5mL). This competitive award, which is not set-aside and features firm fixed-price pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $4,510.23 to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on July 23, 2025, with completion expected by July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly...
- The Defense Logistics Agency awarded a delivery order valued at $10,927.39 to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,587.60 to AmerisourceBergen Drug Corp for FLAREX 0.1% eye drops (5 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of FLAREX 0.1% eye drops in 5 milliliter vials. The contract has a firm fixed price of $4,650.00 and a completion date of August 30, 2024. No set-aside was used for this award. AmerisourceBergen, through its corporate office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
- This is a delivery order for $10,832.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide FLAREX 0.1% eye drops. The contract has a firm fixed price and a completion date of September 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities, including...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a $4,039.03 Firm Fixed Price Delivery Order for the supply of FLAREX 0.1% EYE DROPS 5ML. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,838.84 firm fixed-price delivery order is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product used for ophthalmic treatment. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen is the prime contractor and there are no set-aside requirements indicated. The company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,821.70 delivery order covers the procurement of FLAREX 0.1% eye drops, a specialty ophthalmic medication, with a completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a $346,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562093840 FLAREX 0.1% eye drops. As the prime contractor, Amerisourcebergen will supply five milliliter bottles of the eye drops to meet requirements under the contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from September 8 to September 11, 2023. No major subcontractors or set aside designations were...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGNBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Flarex 0.1% eye drops in a 5ML formulation, valued at $6,379.24. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger pharmaceutical supply agreement. The order is expected to be completed by August 21, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents one transaction within AmerisourceBergen's substantial indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contracting portfolio demonstrates its established capability as a critical pharmaceutical distributor for military and veteran healthcare systems, consistently fulfilling requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 8/20/25 |